FI942908A0 - Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateroskleroosin vastaisina lääkkeinä - Google Patents
Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateroskleroosin vastaisina lääkkeinäInfo
- Publication number
- FI942908A0 FI942908A0 FI942908A FI942908A FI942908A0 FI 942908 A0 FI942908 A0 FI 942908A0 FI 942908 A FI942908 A FI 942908A FI 942908 A FI942908 A FI 942908A FI 942908 A0 FI942908 A0 FI 942908A0
- Authority
- FI
- Finland
- Prior art keywords
- atherosclerosis
- ether compounds
- drugs against
- against hyperlipidemia
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/810,214 US5254549A (en) | 1991-12-19 | 1991-12-19 | New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| PCT/EP1992/002946 WO1993012089A1 (en) | 1991-12-19 | 1992-12-18 | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI942908A FI942908A (fi) | 1994-06-17 |
| FI942908A0 true FI942908A0 (fi) | 1994-06-17 |
Family
ID=25203281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI942908A FI942908A0 (fi) | 1991-12-19 | 1994-06-17 | Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateroskleroosin vastaisina lääkkeinä |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5254549A (he) |
| EP (1) | EP0619807A1 (he) |
| JP (1) | JPH07502271A (he) |
| AU (1) | AU662193B2 (he) |
| CA (1) | CA2085687A1 (he) |
| CZ (1) | CZ283456B6 (he) |
| FI (1) | FI942908A0 (he) |
| HU (1) | HU215844B (he) |
| IL (1) | IL104123A (he) |
| MX (1) | MX9207427A (he) |
| NO (1) | NO301473B1 (he) |
| PL (1) | PL171225B1 (he) |
| RU (1) | RU2120938C1 (he) |
| TW (1) | TW221289B (he) |
| WO (1) | WO1993012089A1 (he) |
| ZA (1) | ZA929867B (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677291A (en) * | 1993-12-10 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| US5627172A (en) * | 1994-03-04 | 1997-05-06 | Natural Supplement Association, Incorporated | Method for reduction of serum blood lipids or lipoprotein fraction |
| US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
| US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| US6114572A (en) * | 1996-11-20 | 2000-09-05 | Hoechst Marion Roussel, Inc. | Substituted phenols and thiophenols useful as antioxidant agents |
| US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
| US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
| US6475526B1 (en) | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
| US20080274209A1 (en) * | 2002-11-04 | 2008-11-06 | Integritas Pharma, Inc. | Methods of treating inflammation |
| US6855341B2 (en) * | 2002-11-04 | 2005-02-15 | Jeffrey B. Smith | Anti-viral compositions and methods of making and using the anti-viral compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE271625C (he) * | ||||
| JPS52125170A (en) * | 1976-04-12 | 1977-10-20 | Yoshitomi Pharmaceut Ind Ltd | Pyridine derivatives |
| DE3431004A1 (de) * | 1984-08-23 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung |
-
1991
- 1991-12-19 US US07/810,214 patent/US5254549A/en not_active Expired - Fee Related
-
1992
- 1992-12-17 IL IL10412392A patent/IL104123A/he not_active IP Right Cessation
- 1992-12-17 CA CA002085687A patent/CA2085687A1/en not_active Abandoned
- 1992-12-17 TW TW081110130A patent/TW221289B/zh active
- 1992-12-18 JP JP5510638A patent/JPH07502271A/ja active Pending
- 1992-12-18 PL PL92304175A patent/PL171225B1/pl unknown
- 1992-12-18 HU HUP9401820A patent/HU215844B/hu not_active IP Right Cessation
- 1992-12-18 RU RU94031210A patent/RU2120938C1/ru active
- 1992-12-18 ZA ZA929867A patent/ZA929867B/xx unknown
- 1992-12-18 EP EP93900104A patent/EP0619807A1/en not_active Ceased
- 1992-12-18 WO PCT/EP1992/002946 patent/WO1993012089A1/en not_active Application Discontinuation
- 1992-12-18 CZ CZ941352A patent/CZ283456B6/cs not_active IP Right Cessation
- 1992-12-18 AU AU31592/93A patent/AU662193B2/en not_active Ceased
- 1992-12-18 MX MX9207427A patent/MX9207427A/es not_active IP Right Cessation
-
1994
- 1994-06-17 NO NO942307A patent/NO301473B1/no unknown
- 1994-06-17 FI FI942908A patent/FI942908A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993012089A1 (en) | 1993-06-24 |
| HU215844B (hu) | 1999-04-28 |
| CZ283456B6 (cs) | 1998-04-15 |
| NO301473B1 (no) | 1997-11-03 |
| PL171225B1 (pl) | 1997-03-28 |
| FI942908A (fi) | 1994-06-17 |
| NO942307D0 (no) | 1994-06-17 |
| IL104123A0 (en) | 1993-05-13 |
| US5254549A (en) | 1993-10-19 |
| CZ135294A3 (en) | 1995-11-15 |
| CA2085687A1 (en) | 1993-06-20 |
| RU2120938C1 (ru) | 1998-10-27 |
| ZA929867B (en) | 1994-06-20 |
| JPH07502271A (ja) | 1995-03-09 |
| NO942307L (no) | 1994-06-17 |
| AU662193B2 (en) | 1995-08-24 |
| IL104123A (he) | 1996-12-05 |
| AU3159293A (en) | 1993-07-19 |
| EP0619807A1 (en) | 1994-10-19 |
| HUT70398A (en) | 1995-10-30 |
| MX9207427A (es) | 1993-11-01 |
| TW221289B (he) | 1994-02-21 |
| HU9401820D0 (en) | 1994-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI981777A (fi) | Farmaseuttinen ainekoostumus | |
| FI934914A (fi) | Farmaceutiska formuleringar | |
| DK0515312T3 (da) | Farmaceutisk præparat | |
| ATA129892A (de) | Pharmazeutische zusammensetzung | |
| FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
| DE69222622D1 (de) | Spritze | |
| FI923581A (fi) | Farmaceutisk kombinationsformation | |
| BR9200058A (pt) | Composto e composicao farmaceutica | |
| MX9200622A (es) | Composicion farmaceutica | |
| NO179254C (no) | Friksjonsmateriale | |
| FI942908A0 (fi) | Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateroskleroosin vastaisina lääkkeinä | |
| FI942963A0 (fi) | Imidatsokinatsoliiniyhdisteitä ja niiden valmistus ja käyttö | |
| FI943581A0 (fi) | Ruisku | |
| DE4294862T1 (de) | Pharmazeutische Komposition | |
| NO934145L (no) | Farmasöytiske forbindelser | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| DE69301633D1 (de) | Reibungsmaterialien | |
| KR920021041U (ko) | 세척기 | |
| MX9202250A (es) | Compuestos de penem y procedimiento para su preparacion. | |
| KR920014910U (ko) | 건축재 | |
| NO942783D0 (no) | Spröyte | |
| BR1100393A (pt) | Composto e formulação farmacêutica | |
| SE9103213D0 (sv) | Farmaceutisk komposition | |
| MC2294A1 (fr) | Seringue non reutilisable | |
| FI914732A0 (fi) | Laitteisto materiaalin sekoittamiseksi ja sen käyttö |